Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Herbology is a healthcare-focused cannabis company and retail brand that specializes in the production and distribution of medical-grade cannabinoid therapies. Originally established as a primary brand under GR Companies Inc. (Grassroots Cannabis), the company was acquired by Curaleaf Holdings in 2020 to expand its footprint in the United States medical cannabis market. Herbology operates a network of dispensaries that emphasize patient education and standardized wellness solutions for conditions such as chronic pain and epilepsy. The company's product portfolio includes a variety of delivery formats, including flower, concentrates, and topicals, all developed with a focus on therapeutic consistency. By integrating clinical-style consultations with retail operations, Herbology aims to bridge the gap between traditional healthcare and medical cannabis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Herbology.